Genito-urinary cancer: publications list
Scientific
E Gazi, J Dwyer, N Lockyer, P Gardner, JC Vickerman, J Miyan, C Hart, M Brown, J Shanks, N Clarke. The combined application of FTIR microspectroscopy and ToF-SIMS imaging in the study of prostate cancer. Faraday Discussions 2003, in press.
Bhatt RI, Brown MD, Hart CA, Gilmore P, Ramani VA, George NJ, Clarke NW. Novel method for the isolation and characterisation of the putative prostatic stem cell. Cytometry. 2003 Aug;54A(2):89-99.
E Gazi, J Dwyer, P Gardner, A Ghanbari-Siahkali, AP Wade, J Miyan, NP Lockyer, JC Vickerman, NW Clarke, JH Shanks, LJ Scott, CA Hart, M Brown. Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot study. Journal of Pathology 2003. Published online 1st July 2003.
Shackley DC, Haylett A, Whitehurst C, Betts CD, O'Flynn K, Clarke NW, Moore JV. Comparison of the cellular molecular stress responses after treatments used in bladder cancer. BJU Int. 2002 Dec;90(9):924-32.
Hart CA, Scott LJ, Bagley S, Bryden AA, Clarke NW, Lang SH. Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies. Br J Cancer. 2002 Apr 8;86(7):1136-42.
Bryden AA, Hoyland JA, Freemont AJ, Clarke NW, Schembri Wismayer D, George NJ. E- cadherin and beta-catenin are down-regulated in prostatic bone metastases. BJU Int. 2002 Mar;89(4):400-3.
Bryden AA, Hoyland JA, Freemont AJ, Clarke NW, George NJ. Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases. Br J Cancer. 2002 Feb 1;86(3):322-5.
Collis SJ, Sangar VK, Tighe A, Roberts SA, Clarke NW, Hendry JH, Margison GP. Development of a novel rapid assay to assess the fidelity of DNA double-strand-break repair in human tumour cells. Nucleic Acids Res. 2002 Jan 15;30(2):E1.
Bryden AA, Freemont AJ, Clarke NW, George NJ. Ki-67 index in metastatic prostate cancer. Eur Urol. 2001 Dec;40(6):673-6.
McIntyre IG, Clarke RB, Anderson E, Clarke NW, George NJ. Molecular prediction of progression in patients with conservatively managed prostate cancer. Urology. 2001 Nov;58(5):762-6.
Scott LJ, Clarke NW, George NJ, Shanks JH, Testa NG, Lang SH. Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion. Br J Cancer. 2001 May 18;84(10):1417-23.
Scott LJ, Clarke NW, Sharrard MS, George NJ, Lang SH. Invasive phenotype of primary human prostatic epithelial cells. Prostate Cancer Prostatic Dis. 2000 Dec;3(S1):S8.
McIntyre IG, Spreckley K, Clarke RB, Anderson E, Clarke NW, George NJ. Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells. Br J Cancer. 2000 Oct;83(8):992-7.
Bryden AA, Freemont AJ, Clarke NW, George NJ. Paradoxical expression of E-cadherin in prostatic bone metastases. BJU Int. 1999 Dec;84(9):1032-4.
Lang SH, Clarke NW, George NJ, Testa NG. Scatter factor influences the formation of prostate epithelial cell colonies on bone marrow stroma in vitro. Clin Exp Metastasis. 1999 Jun;17(4):333-40.
Lang SH, Clarke NW, George NJ, Allen TD, Testa NG. Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma. Prostate. 1998 Feb 15;34(3):203-13.
Lang SH, Clarke NW, George NJ, Testa NG. Primary prostatic epithelial cell binding to human bone marrow stroma and the role of alpha2beta1 integrin. Clin Exp Metastasis. 1997 May;15(3):218-27.
Clarke NW, McClure J, George NJ. Osteoblast function and osteomalacia in metastatic prostate cancer. Eur Urol. 1993;24(2):286-90.
Clarke NW, McClure J, George NJ. Disodium pamidronate identifies differential osteoclastic bone resorption in metastatic prostate cancer. Br J Urol. 1992 Jan;69(1):64-70.
Clarke NW, McClure J, George NJ. Morphometric evidence for bone resorption and replacement in prostate cancer. Br J Urol. 1991 Jul;68(1):74-80.
Clarke NW, Holbrook IB, McClure J, George NJ. Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study. Br J Cancer. 1991 Mar;63(3):420-3.
Clarke NW, McClure J, George NJ. Preferential preservation of bone mineralisation by LHRH agonists in the treatment of metastatic prostate cancer. Eur Urol. 1991;19(2):114-7.
Steven FS, Griffin MM, Williams LA, Clarke NW, Maier H. Labelling of tumour cells with a biotinylated inhibitor of a cell surface protease. J Enzyme Inhib. 1991;4(4):337-46.
Clinical
Shackley DC, Briggs C, Gilhooley A, Whitehurst C, O'Flynn KJ, Betts CD, Moore JV, Clarke NW. Photodynamic therapy for superficial bladder cancer under local anaesthetic. BJU Int. 2002 May;89(7):665-70.
Denton AS, Clarke NW, Maher EJ. Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev. 2002;(3):CD001773. Review.
Clarke, N. W.. Renal Cell Carcinoma, Molecular Biology, Immunology, and Clinical Management. BJU International. 87(3):282, February 2001
Shackley DC, Briggs C, Whitehurst C, Betts CD, O'Flynn KJ, Clarke NW, Moore JV. Photodynamic therapy for superficial bladder cancer. Expert Rev Anticancer Ther. 2001 Dec;1(4):523-30. Review.
Naik KS, Carrington BM, Yates W, Clarke NW. The post-cystectomy pseudotumour sign: MRI appearances of a modified chronic pelvic haematoma due to retained haemostatic gauze. Clin Radiol. 2000 Dec;55(12):970-4.
Shackley DC, Brew CJ, Bryden AA, Anderson ID, Carlson GL, Scott NA, Clarke NW. The staged management of complex entero-urinary fistulae. BJU Int. 2000 Oct;86(6):624-9.
Shackley DC, Whitehurst C, Moore JV, George NJ, Betts CD, Clarke NW. Light penetration in bladder tissue: implications for the intravesical photodynamic therapy of bladder tumours. BJU Int. 2000 Oct;86(6):638-43.
Shackley DC, Whitehurst C, Clarke NW, Betts C, Moore JV. Photodynamic therapy. J R Soc Med. 1999 Nov;92(11):562-5. Review.
Chaudhary R, Bromley M, Clarke NW, Betts CD, Barnard RJ, Ryder WD, Kumar S. Prognostic relevance of micro-vessel density in cancer of the urinary bladder. Anticancer Res. 1999 Jul-Aug;19(4C):3479-84.
Banerjee SS, Eyden BP, McVey RJ, Bryden AA, Clarke NW. Primary peripheral primitive neuroectodermal tumour of urinary bladder. Histopathology. 1997 May;30(5):486-90.
Clarke NW. The management of localized prostate cancer. Br J Hosp Med. 1996 Mar 6- 19;55(5):232-3.
Lau MW, Temperley DE, Mehta S, Johnson RJ, Barnard RJ, Clarke NW. Urinary tract obstruction and nephrostomy drainage in pelvic malignant disease. Br J Urol. 1995 Nov;76(5):565-9.
McMahon RF, McWilliam LJ, Clarke NW, George NJ. Altered saccharide sequences in two groups of patients with metastatic prostatic carcinoma. Br J Urol. 1994 Jul;74(1):80-5.
Chapman SM, Wemyss-Holden GD, Clarke NW. Urinary incontinence following urethral Wallstent insertion. Br J Urol. 1994 May;73(5):586.
Clarke NW, McClure J, George NJ. The effects of orchidectomy on skeletal metabolism in metastatic prostate cancer. Scand J Urol Nephrol. 1993;27(4):475-83.
Clarke NW, Maxwell AJ. Primary lymphoma of the urinary bladder. Br J Radiol. 1991 Aug;64(764):761-2.
Clarke NW, Jones DA, Tames F, Laing I, George NJ. Disturbance in sodium regulating hormones in chronic obstructive uropathy. Br J Urol. 1991 Aug;68(2):118-21.
Clarke NW, Gough DC, Cohen SJ. Neonatal urological ultrasound: diagnostic inaccuracies and pitfalls. Arch Dis Child. 1989 Apr;64(4):578-80.
Cross PA, Clarke NW. Malignant nerve sheath tumour with epithelial elements. Histopathology. 1988 May;12(5):547-9.